Neogenomics INC (NEO) Stock Price Rose While First Light Asset Management LLC Has Raised Its Stake

August 9, 2018 - By Robert Shackelford

NeoGenomics, Inc. (NASDAQ:NEO) LogoInvestors sentiment increased to 1.43 in Q1 2018. Its up 0.60, from 0.83 in 2017Q4. It improved, as 8 investors sold NEO shares while 34 reduced holdings. 19 funds opened positions while 41 raised stakes. 63.35 million shares or 0.63% less from 63.75 million shares in 2017Q4 were reported. First Allied Advisory has invested 0.01% in NeoGenomics, Inc. (NASDAQ:NEO). 1492 Limited holds 364,764 shares. Artisan Prns Ltd Partnership has 0.04% invested in NeoGenomics, Inc. (NASDAQ:NEO) for 2.16M shares. Falcon Point Cap Ltd Liability Com reported 1.30M shares or 2.11% of all its holdings. 21,864 were reported by Aqr Management Limited Liability Company. Segall Bryant Hamill Lc holds 0.08% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO) for 441,380 shares. General holds 15.00M shares or 69.89% of its portfolio. Bluecrest Cap Mngmt Limited holds 0% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO) for 10,295 shares. Blair William & Commerce Il has 292,957 shares. Northwestern Mutual Wealth Management Co stated it has 0% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO). The Pennsylvania-based Penn Capital Mngmt Co Incorporated has invested 0.19% in NeoGenomics, Inc. (NASDAQ:NEO). Emerald Mutual Fund Advisers Tru, Pennsylvania-based fund reported 282,506 shares. Jpmorgan Chase Company reported 0% of its portfolio in NeoGenomics, Inc. (NASDAQ:NEO). Gamco Investors Et Al holds 0.02% in NeoGenomics, Inc. (NASDAQ:NEO) or 342,379 shares. Howland Cap Mgmt Limited Liability Corp holds 0.01% in NeoGenomics, Inc. (NASDAQ:NEO) or 21,782 shares.

Since May 10, 2018, it had 0 buys, and 9 sales for $12.97 million activity. BALLIET JENNIFER sold $146,055 worth of stock or 13,000 shares. SHOVLIN ROBERT J. sold $169,786 worth of stock or 12,941 shares. On Thursday, May 10 the insider ROSS STEVEN A sold $883,949.

First Light Asset Management Llc increased its stake in Neogenomics Inc (NEO) by 23.72% based on its latest 2018Q1 regulatory filing with the SEC. First Light Asset Management Llc bought 912,730 shares as the company’s stock rose 36.15% while stock markets declined. The institutional investor held 4.76M shares of the health care company at the end of 2018Q1, valued at $38.84 million, up from 3.85 million at the end of the previous reported quarter. First Light Asset Management Llc who had been investing in Neogenomics Inc for a number of months, seems to be bullish on the $1.11B market cap company. The stock increased 0.35% or $0.0475 during the last trading session, reaching $13.5875. About 41,601 shares traded. NeoGenomics, Inc. (NASDAQ:NEO) has risen 53.64% since August 9, 2017 and is uptrending. It has outperformed by 41.07% the S&P500.

First Light Asset Management Llc, which manages about $154.73M and $455.37 million US Long portfolio, decreased its stake in Nektar Therapeutics (NASDAQ:NKTR) by 51,655 shares to 300,086 shares, valued at $31.89M in 2018Q1, according to the filing.

More notable recent NeoGenomics, Inc. (NASDAQ:NEO) news were published by: which released: “The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed’s Antibiotic Faces FDA Panel” on August 07, 2018, also with their article: “Pre-Open Movers 08/07: (VCEL) (MNK) (TWLO) Higher; (ONCE) (GEMP) (ZG) Lower (more…)” published on August 07, 2018, published: “NeoGenomics Announces Proposed Public Offering of Common Stock” on August 06, 2018. More interesting news about NeoGenomics, Inc. (NASDAQ:NEO) were released by: and their article: “Earnings Preview For NeoGenomics” published on July 23, 2018 as well as‘s news article titled: “NeoGenomics Inc. 2018 Q2 – Results – Earnings Call Slides” with publication date: July 24, 2018.

NeoGenomics, Inc. (NASDAQ:NEO) Ratings Coverage

Among 3 analysts covering NeoGenomics (NASDAQ:NEO), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. NeoGenomics had 3 analyst reports since April 16, 2018 according to SRatingsIntel. The rating was upgraded by BTIG Research on Monday, April 16 to “Outperform”. First Analysis downgraded the shares of NEO in report on Wednesday, May 2 to “Equal-Weight” rating. The stock of NeoGenomics, Inc. (NASDAQ:NEO) has “Buy” rating given on Tuesday, June 26 by Stephens.

NeoGenomics, Inc. (NASDAQ:NEO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.